Association of haplotypes of inflammation-related genes with gastric preneoplastic lesions in African Americans and Caucasians.
Identification of biomarkers is needed for development of screening programs to prevent gastric cancer. Because racial differences exist in cancer rates, we aimed to evaluate the association between polymorphisms in inflammation-related genes and gastric preneoplastic lesions in African Americans and Caucasians from Louisiana, USA. Gastric biopsies from 569 adults (361 African Americans and 208 Caucasians) undergoing diagnostic endoscopy were used for histological diagnosis and genomic DNA extraction. Polymorphisms within eight genes (IL1B, IL8, IL6, TNF, PTGS2, ARG1, IL10 and TGFB1) were investigated by TaqMan. The cagA status of Helicobacter pylori infection was assessed by PCR. Haplotype logistic regression models were used to identify variables associated with intestinal metaplasia or dysplasia. African Americans carrying the haplotype IL1B-511T/-31C/+3954T, which includes the three risk-associated alleles at the IL1B locus, were more likely to being diagnosed with intestinal metaplasia or dysplasia than those carrying the most common haplotype T-C-C (adjusted OR: 2.51, 95% CI: 1.1-5.5). None of the polymorphisms were associated with intestinal metaplasia and dysplasia in Caucasians. Age and cagA-positive status were independent factors associated with these lesions. Haplotypes at the IL1B locus may participate in mediating the susceptibility to gastric carcinogenesis and might be useful as markers of advanced premalignant lesions in African Americans. Interestingly, carriage of IL1B+3954T allele seems to be the key factor, even though the role played by other polymorphisms cannot be excluded.
Zabaleta
Jovanny
J
Department of Pediatrics, LSUHSC, New Orleans, LA 70112, USA. jzabal@lsuhsc.edu
Camargo
Maria C
MC
Ritchie
Marylyn D
MD
Piazuelo
Maria B
MB
Sierra
Rosa A
RA
Turner
Stephen D
SD
Delgado
Alberto
A
Fontham
Elizabeth T H
ET
Schneider
Barbara G
BG
Correa
Pelayo
P
Ochoa
Augusto C
AC
D000328:Adult; D044383:Black People / Q000235:genetics*; D015992:Body Mass Index; D004273:DNA, Neoplasm / Q000235:genetics / Q000302:isolation & purification; D005260:Female; D005753:Gastric Mucosa / Q000473:pathology; D006239:Haplotypes; D016481:Helicobacter Infections / Q000150:complications / Q000453:epidemiology; D016480:Helicobacter pylori; D006801:Humans; D007249:Inflammation / Q000235:genetics*; D020382:Interleukin-18 / Q000235:genetics; D008145:Louisiana; D008297:Male; D008875:Middle Aged; D011110:Polymorphism, Genetic; D020641:Polymorphism, Single Nucleotide; D011230:Precancerous Conditions / Q000235:genetics*; D013274:Stomach Neoplasms / Q000150:complications / Q000235:genetics* / Q000473:pathology; D044465:White People / Q000235:genetics*; D001741:Black or African American
D004273:DNA, Neoplasm; D020382:Interleukin-18
Am J Hum Genet. 2002 Feb;70(2):425-34
11791212
Gastroenterology. 2001 Oct;121(4):823-9
11606496
J Biol Chem. 2000 Jun 16;275(24):18138-44
10747905
CA Cancer J Clin. 2006 Mar-Apr;56(2):69-83
16514135
Hum Mol Genet. 2006 Feb 15;15(4):519-29
16399797
Hum Hered. 2002;53(2):79-91
12037407
Lancet Oncol. 2008 Mar;9(3):279-87
18308253
Cancer Biol Ther. 2008 Feb;7(2):157-62
18059184
Eur J Cancer. 2009 Sep;45(14):2562-8
19375306
Int J Cancer. 2006 Feb 1;118(3):649-57
16114018
Am J Hum Genet. 1998 Dec;63(6):1872-85
9837839
Annu Rev Physiol. 2001;63:49-76
11181948
Am J Surg Pathol. 1996 Oct;20(10):1161-81
8827022
Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2251-7
15598788
J Microbiol Methods. 2003 Dec;55(3):625-33
14607406
Cancer Causes Control. 2006 Feb;17(1):117-25
16411061
Br J Cancer. 2008 Apr 22;98(8):1443-51
18319718
Genetics. 1997 Oct;147(2):927-30
9335624
Gastroenterology. 2006 Jun;130(7):1975-84
16762620
Gut. 2005 Jun;54(6):764-8
15888780
Biochem J. 2008 Mar 1;410(2):225-35
18254728
J Clin Invest. 2007 Jan;117(1):60-9
17200707
Gut. 2001 Jun;48(6):743-7
11358884
Clin Gastroenterol Hepatol. 2006 Jun;4(6):709-16
16765306
Cancer Epidemiol Biomarkers Prev. 2006 Sep;15(9):1674-87
16985030
Genes Immun. 2006 Dec;7(8):640-6
16971953
Nature. 2000 Mar 23;404(6776):398-402
10746728
Cancer Res. 1995 May 15;55(10):2111-5
7743510
CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
15761078
Am J Gastroenterol. 1999 May;94(5):1218-23
10235197
Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2631-6
18086767
Eur J Clin Invest. 1992 Jun;22(6):396-402
1353022
Bioinformatics. 2005 Jan 15;21(2):263-5
15297300
Lab Invest. 1995 Dec;73(6):760-70
8558837
Clin Exp Med. 2005 Dec;5(4):169-76
16362796
Lancet. 1975 Jul 12;2(7924):58-60
49653
Am J Gastroenterol. 2006 Jan;101(1):163-71
16405550
Gastroenterology. 2003 May;124(5):1193-201
12730860
IARC Monogr Eval Carcinog Risks Hum. 1994;61:1-241
7715068
Cancer Res. 2004 Aug 15;64(16):5839-49
15313928
Gut. 1998 Feb;42(2):227-34
9536948
Am J Surg Pathol. 2000 Feb;24(2):167-76
10680883
J Clin Invest. 1998 Oct 1;102(7):1369-76
9769329
J Clin Microbiol. 1998 Sep;36(9):2597-603
9705399
CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66
17237035
Int J Cancer. 2007 Mar 15;120(6):1330-5
17187359
Mol Immunol. 1997 Apr;34(5):391-9
9293772